162502-53-6 Usage
General Description
4-Chloro-1-methyl-1H-indazole is a synthetic aromatic chemical compound, belonging to the class of organic compounds known as indazoles. As its name suggests, it has a molecular structure that consists of a chloro group at the fourth position and a methyl group at the first position of an indazole ring. Its systematic name is 4-chloro-1-methyl-1H-indazole, reflecting its structural characteristics. 4-Chloro-1-methyl-1H-indazole is widely used in scientific research for the synthesis of various complex molecules and pharmaceuticals but does not occur naturally. Specific details about its physical properties such as melting point, boiling point, or solubility may vary depending on its specific form or preparation.
Check Digit Verification of cas no
The CAS Registry Mumber 162502-53-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,5,0 and 2 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 162502-53:
(8*1)+(7*6)+(6*2)+(5*5)+(4*0)+(3*2)+(2*5)+(1*3)=106
106 % 10 = 6
So 162502-53-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H7ClN2/c1-11-8-4-2-3-7(9)6(8)5-10-11/h2-5H,1H3
162502-53-6Relevant articles and documents
A method for the regioselective synthesis of 1-alkyl-1H-indazoles
Liu, Han-Jun,Hung, Shiang-Fu,Chen, Chuan-Lin,Lin, Mei-Huey
, p. 3907 - 3912 (2013/06/27)
A method for the regioselective synthesis of 3-unsubstituted 1-alkyl-1H-indazoles, starting with 2-halobenzonitriles and N-alkylhydrazines, is described. The two-step reaction pathway proceeds through the intermediacy of 1-alkyl-3-amino-1H-indazoles follo
METHODS FOR MAKING CENTRAL NERVOUS SYSTEM AGENTS THAT ARE TRPV1 ANTAGONISTS
-
Page/Page column 43-44, (2009/10/22)
The invention discloses compounds of formula ( II ): and methods of making the compounds, which are VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
